Cristine Delnevo, a prominent figure in the field, is the subject of translation.
Cristine Delnevo, the Director of the Rutgers Tobacco Research Center and a Professor of Health Behavior, Society, and Policy at Rutgers School of Public Health, has been appointed as the Chair of the Tobacco Products Scientific Advisory Committee (TPSAC) by the U.S. Food and Drug Administration (FDA). Her tenure will last until January 31, 2025.
In March 2021, Delnevo was appointed as a member of the Tobacco Products Scientific Advisory Committee (TPSAC). TPSAC was established in 2009 to review and evaluate safety, dependence, and health issues related to tobacco products and provide recommendations, information, and advice to the FDA Commissioner. Committee members are chosen by the FDA Commissioner from individuals with medical, medical ethics, scientific, or technical expertise related to the manufacturing, evaluation, or use of tobacco products.
Delnevo stated in a press release issued by Rutgers, "Since the signing of the Family Smoking Prevention and Tobacco Control Act in 2009, I have placed great importance on the FDA's advisory committees. As mandated by the Tobacco Control Act, these committees play an important role in several areas, perhaps most notably in the review of modified risk tobacco products.
Delnevo's expertise covers tobacco behavior trends at the population level, particularly in non-cigarette tobacco products such as cigars and electronic cigarettes, tobacco control policies and regulations, and research methods for surveys.
Statement:
This article is compiled from third-party information and is only intended for industry exchange and learning.
This article does not represent the viewpoint of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The compilation of this article is only for industry exchange and research purposes.
Due to limitations in the level of translation, the translated article may not accurately convey the original meaning. Please refer to the original text for the most accurate version.
2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau or Taiwan-related, and foreign-related statements and positions.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
